Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

4(50.0%)

Phase 2

3(37.5%)

Phase 3

1(12.5%)

8Total

Phase 1(4)

Phase 2(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00454532Phase 1Completed

A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Role: lead

NCT00906308Phase 3Unknown

A Study of MF101 in Postmenopausal Women

Role: lead

NCT00453089Phase 1Unknown

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

Role: lead

NCT00907959Phase 2Unknown

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Role: lead

NCT01300078Phase 1Unknown

A Clinical Trial Assessing Safety of MF101 for Hot Flushes

Role: lead

NCT00453297Phase 1Terminated

Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components

Role: lead

NCT00119665Phase 2Completed

Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes

Role: lead

NCT00454441Phase 2Completed

Sleep Quality in CHIMES (MF101)

Role: lead

All 8 trials loaded